Cytosorbents (CTSO) Research & Development (2010 - 2026)
Cytosorbents posted quarterly Research & Development of $459000.0 for Q1 2026, down 53.12% year-on-year from $979000.0 in Q1 2025, and down 53.12% on a QoQ basis from $979000.0 in Q1 2025.
Cytosorbents (CTSO) has 17 years of Research & Development data on file, last reported at $459000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 53.12% year-over-year to $459000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 28.59% YoY), and the FY2025 full-year result was $3.4 million, down 32.18% from the prior year.
- Research & Development for Q1 2026 stood at $459000.0, down from $979000.0 in the prior quarter.
- Across five years, Research & Development topped out at $4.2 million in Q1 2022 and bottomed at -$640040.0 in Q4 2024.
- The 5-year median for Research & Development is $3.3 million (2022), against an average of $2.7 million.
- The widest annual swing landed in 2022, when Research & Development soared 85.95%; it then slumped 115.62% in 2024.
- A 5-year view of Research & Development shows it stood at $3.4 million in 2022, then gained by 20.42% to $4.1 million in 2023, then tumbled by 115.62% to -$640040.0 in 2024, then jumped by 252.96% to $979000.0 in 2025, then plunged by 53.12% to $459000.0 in 2026.
- The last three Research & Development figures came in at $459000.0 (Q1 2026), $979000.0 (Q1 2025), and -$640040.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 459,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 459,000.00 |
| Mar 31, 2025 | 979,000.00 |
| Dec 31, 2024 | -640,040.00 |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | 3.29 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 6.14 Mn |
| Sep 30, 2021 | 4.26 Mn |
| Jun 30, 2021 | 3.70 Mn |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 2.69 Mn |
| Sep 30, 2020 | 1.75 Mn |
| Jun 30, 2020 | 2.41 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 3.56 Mn |
| Sep 30, 2019 | 3.19 Mn |
| Jun 30, 2019 | 2.93 Mn |
| Mar 31, 2019 | 2.42 Mn |
| Dec 31, 2018 | 2.42 Mn |
| Sep 30, 2018 | 1.94 Mn |
| Jun 30, 2018 | 1.58 Mn |
| Mar 31, 2018 | 1.73 Mn |
| Dec 31, 2017 | 1.67 Mn |
| Sep 30, 2017 | 643,193.00 |
| Jun 30, 2017 | 458,027.00 |
| Mar 31, 2017 | 469,547.00 |
| Dec 31, 2016 | 952,746.00 |
| Sep 30, 2016 | 1.17 Mn |
| Jun 30, 2016 | 1.09 Mn |
| Mar 31, 2016 | 856,122.00 |
| Dec 31, 2015 | 1.25 Mn |
| Sep 30, 2015 | 866,334.00 |
| Jun 30, 2015 | 801,656.00 |
| Mar 31, 2015 | 951,028.00 |
| Dec 31, 2014 | 967,700.00 |
| Sep 30, 2014 | 880,292.00 |
| Jun 30, 2014 | 346,993.00 |
| Mar 31, 2014 | 236,774.00 |
| Dec 31, 2013 | 32,440.00 |
| Sep 30, 2013 | 294,198.00 |
| Jun 30, 2013 | 708,159.00 |
| Mar 31, 2013 | 704,141.00 |
| Dec 31, 2012 | 678,082.00 |
| Sep 30, 2012 | 554,266.00 |
| Jun 30, 2012 | 715,750.00 |
| Mar 31, 2012 | 632,854.00 |
| Dec 31, 2011 | 494,672.00 |
| Sep 30, 2011 | 779,589.00 |
| Jun 30, 2011 | 854,827.00 |
| Mar 31, 2011 | 759,157.00 |
| Dec 31, 2010 | 197,224.00 |
| Sep 30, 2010 | 526,043.00 |
| Jun 30, 2010 | 352,888.00 |